Perftoran®-Reference-Cited by-同舟云学术

Perftoran®

Published:2006 Issue: Volume: Page:288-297
ISSN:
Container-title:Blood Substitutes
language:
Short-container-title:

Author:

Maevsky Eugene I.,Ivanitsky Henrikh R.,Islamov Bahram I.,Moroz Victor V.,Bogdanova Liudmila A.,Karmen Natalia B.,Pushkin Sergey Yu.,Maslennikov Igor A.

Publisher

Elsevier

Reference40 articles.

1. Perftoran infusion at the acute myocardial infarct;Aliev;Anesthesiol. Reanimatol,2002

2. Assessment of possibilities of using fluorocarbon cardioplegia for antiischemic protection of the myocardium;Beloyartsev;Vestn. Akad. Med. Nauk. SSSR,1986

3. Possibility to optimize oxygen transport by Perftoran at the sur-gery treatment of patients with lung tumour;Biryukov,2001

4. Cardiorespiratory consequences of fluorocarbon reactions in dogs;Faithfull;Biomat. Artif. Cells Artif. Organs,1988

5. Perftoran – plasma substitute with an oxygen transport function;Golubev;Bull. Exper. Biol. Med.,1998

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perftoran: History, Clinical Trials, and Pathway Forward;Blood Substitutes and Oxygen Biotherapeutics;2022

2. Perfluorocarbons for the treatment of decompression illness: how to bridge the gap between theory and practice;European Journal of Applied Physiology;2019-11-04

3. Perftoran (Vidaphor)—Introduction to Western Medicine;Shock;2019-10

4. Oxygen Carriers: Are They Enough for Cellular Support?;Springer Series in Translational Stroke Research;2017

5. Oxygen DeliveryviaAllosteric Effectors of Hemoglobin and Blood Substitutes;Burger's Medicinal Chemistry and Drug Discovery;2010-01-29